CLINICAL_TRIALS
trial_result
· 2020-01-28
Clinical Trial Update: A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Summary
Phase 2 trial of BMS-986036 in non-alcoholic steatohepatitis (NASH) has completed, with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Non-Alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-01-28